Meitheal Pharmaceuticals, Inc.

Date: 01/27/2021

Product Description

Cisatracurium Besylate Injection, USP 10mg per 5mL

Recall Reason Description

Mislabeling

Company Name

Meitheal Pharmaceuticals, Inc.

US FDA Link:https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/meitheal-pharmaceuticals-inc-issues-voluntary-nationwide-recall-cisatracurium-besylate-injection-usp